DarioHealth Corp. reported its financial results for the third quarter of 2025, revealing total revenues of $5.0 million, a decrease of 32.5% from $7.4 million in the same period last year. For the nine months ending September 30, 2025, revenues totaled $17.1 million, down from $19.4 million in the prior year. The company experienced a net loss of $10.5 million for the quarter, compared to a loss of $12.3 million in Q3 2024. The net loss attributable to common shareholders for the nine-month period was $51.5 million, significantly higher than the $28.7 million loss reported in the same period last year.
The decline in revenue was attributed to a reduction in service revenues, which fell to $3.2 million from $5.6 million year-over-year, while consumer hardware revenues remained relatively stable at $1.8 million. The company noted that the decrease in service revenues was primarily due to changes in customer contracts and market conditions. DarioHealth's operating expenses also decreased to $12.5 million from $15.9 million in the previous year, reflecting cost-cutting measures and a reduction in research and development spending.
DarioHealth has made strategic moves to enhance its market position, including the acquisition of Twill, Inc. in February 2024, which is expected to bolster its digital therapeutic offerings. The company has also implemented a reverse stock split at a ratio of 20-for-1, effective August 28, 2025, to improve its stock price and attract institutional investors. As of September 30, 2025, DarioHealth reported a total of 6.8 million shares outstanding, a significant increase from 1.9 million shares at the end of 2024.
Operationally, DarioHealth's customer base has seen fluctuations, with a notable decrease in major customer contributions to revenue. The company reported that no single customer accounted for a significant portion of its revenue in the recent quarter, compared to previous periods where major customers represented a substantial share. The company continues to focus on expanding its geographic reach and enhancing product adoption rates, although specific metrics on user engagement and market share were not disclosed in the filing.
Looking ahead, DarioHealth's management expressed cautious optimism regarding future growth, emphasizing the need for continued investment in product development and market penetration. The company anticipates that its recent strategic initiatives, including the integration of Twill's technology and the potential for new partnerships, will support its transition to profitability. However, DarioHealth acknowledged the ongoing challenges posed by market conditions and the necessity of securing additional funding to sustain operations and support growth initiatives.
About DarioHealth Corp.
DarioHealth is a global digital health company specializing in whole-person health management. It offers personalized digital therapeutics and virtual care solutions across physical, mental, and behavioral health conditions. Serving employers, health plans, pharmaceutical companies, and consumers, it leverages AI, data analytics, and engaging user experiences to deliver improved clinical outcomes, cost savings, and high ROI through integrated, scalable platforms focused on chronic disease, mental health, and preventive care.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.